{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:55:57Z","timestamp":1759683357034},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,8,5]],"date-time":"2012-08-05T00:00:00Z","timestamp":1344124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00213-012-2818-6","type":"journal-article","created":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T10:37:34Z","timestamp":1344076654000},"page":"247-249","source":"Crossref","is-referenced-by-count":6,"title":["Sulpiride and refractory panic disorder"],"prefix":"10.1007","volume":"223","author":[{"given":"Emerson A.","family":"Nunes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael C.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moema","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Cardoso","family":"de Oliveira e Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9rgio","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A. S.","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar M.","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen B.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime E. C.","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio E.","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,5]]},"reference":[{"key":"2818_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S1092852900020216","volume":"14","author":"RM Berman","year":"2009","unstructured":"Berman RM, Fava M, Thase ME et al (2009) Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. CNS Spectr 14:197\u2013206","journal-title":"CNS Spectr"},{"key":"2818_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s002130050914","volume":"143","author":"E Cavazzuti","year":"1999","unstructured":"Cavazzuti E, Bertolini A, Vergoni AV et al (1999) l-Sulpiride, at a low, non-neuroleptic dose, prevents conditioned fear stress-induced freezing behavior in rats. Psychopharmacology (Berl) 143:20\u201323","journal-title":"Psychopharmacology (Berl)"},{"key":"2818_CR3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.2011.11010087","volume":"168","author":"JS Comer","year":"2011","unstructured":"Comer JS, Mojtabai R, Olfson M (2011) National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. Am J Psychiatry 168:1057\u20131065","journal-title":"Am J Psychiatry"},{"key":"2818_CR4","doi-asserted-by":"crossref","first-page":"w770","DOI":"10.1377\/hlthaff.28.5.w770","volume":"28","author":"S Crystal","year":"2009","unstructured":"Crystal S, Olfson M, Huang C, Pincus H, Gerhard T (2009) Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff 28:w770\u2013w781","journal-title":"Health Aff"},{"key":"2818_CR5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pneurobio.2009.10.010","volume":"90","author":"MP Mora de la","year":"2010","unstructured":"de la Mora MP, Gallegos-Cari A, Arizmendi-Garcia Y, Marcellino D, Fuxe K (2010) Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis. Prog Neurobiol 90:198\u2013216","journal-title":"Prog Neurobiol"},{"issue":"10","key":"2818_CR6","first-page":"48","volume":"4","author":"RL Holt","year":"2007","unstructured":"Holt RL, Lydiard RB (2007) Management of treatment-resistant panic disorder. Psychiatry 4(10):48\u201359","journal-title":"Psychiatry"},{"key":"2818_CR7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","volume":"10","author":"S Miyamoto","year":"2005","unstructured":"Miyamoto S, Duncan GE, Marx CE, Lieberman JA (2005) Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10:79\u2013104","journal-title":"Mol Psychiatry"},{"key":"2818_CR8","first-page":"125","volume":"89","author":"EM Pich","year":"1986","unstructured":"Pich EM, Samanin R (1986) Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental models in rats: possible role of dopamine. Psychopharmacology (Berl) 89:125\u2013130","journal-title":"Psychopharmacology (Berl)"},{"key":"2818_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0163-1047(88)90804-7","volume":"50","author":"S Puglisi-Allegra","year":"1988","unstructured":"Puglisi-Allegra S, Cabib S (1988) Pharmacological evidence for a role of D2 dopamine receptors in the defensive behaviour of the mouse. Behav Neural Biol 50:98\u2013111","journal-title":"Behav Neural Biol"},{"key":"2818_CR10","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0091-3057(94)90253-4","volume":"49","author":"RJ Rodgers","year":"1994","unstructured":"Rodgers RJ, Nikulina EM, Cole JC (1994) Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 49:985\u2013995","journal-title":"Pharmacol Biochem Behav"},{"key":"2818_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2007-979218","volume":"32","author":"E Ruther","year":"1999","unstructured":"Ruther E, Degner D, Munzel U et al (1999) Antidepressant action of sulpiride. Results of a placebo-controlled double-blind trial. Pharmacopsychiatry 32:127\u2013135","journal-title":"Pharmacopsychiatry"},{"issue":"suppl 20","key":"2818_CR12","first-page":"22","volume":"59","author":"D Sheehan","year":"1998","unstructured":"Sheehan D, Lecrubier Y, Sheehan KH et al (1998) The Mini International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(suppl 20):22\u201333","journal-title":"J Clin Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2818-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-012-2818-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2818-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:12:39Z","timestamp":1558642359000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-012-2818-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,5]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["2818"],"URL":"https:\/\/doi.org\/10.1007\/s00213-012-2818-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,5]]}}}